Complex array of cytokines released by vasoactive intestinal peptide

Douglas E. Brenneman, Terry M. Phillips, Janet Hauser, Joanna M. Hill, Catherine Y. Spong, Illana Gozes

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

A complex mixture of five cytokines has been shown to be released by vasoactive intestinal peptide (VIP). Cytokines were measured in paired samples of culture medium and astroglial cytosol by capillary electrophoresis. This is the first description of VIP-mediated release for TNF-α, IL-3, G-CSF and M-CSF from astrocyte cultures. Kinetic studies after VIP treatment demonstrated a gradual but incomplete depletion of cytosolic cytokine levels, with differences observed among the cytokines. Significant increases in release were apparent within 15-30 min for all cytokines. As the recognized VIP receptors (VPAC1 and VPAC2) are linked to adenylate cyclase and also interact with pituitary adenylate cyclase activating polypeptide-38 (PACAP-38), both this homologous peptide and 8-bromo cAMP were investigated and compared to VIP-mediated release. Treatment with 1 mM 8-bromo cAMP produced cytokine release similar in amount to 0.1 nM PACAP-38, but significantly less (<50%) in comparison to 0.1 nM VIP. PACAP-38 and VIP exhibited similar EC 50's for the release of G-CSF and TNF-α; however, the maximal release was 4-6 times greater for VIP than for PACAP-38. This similarity in potency suggested a VPAC-like receptor; however, the greater efficacy for VIP in comparison to PACAP-38, combined with a lack of cAMP production at subnanomolar concentrations of VIP, suggested a mechanism not currently associated with VPAC receptors. For M-CSF, IL-3 and IL-6, the EC50's of VIP were 3-30 times more potent than those of PACAP-38 in producing release. These studies suggested that multiple mechanisms mediate cytokine release in astrocytes: (1) a low efficacy release produced by PACAP-38 that is cAMP-mediated and (2) a high efficacy, VIP-preferring mechanism that was not linked to cAMP. In summary, subnanomolar concentrations of VIP released a complex array of cytokines from astrocytes that may contribute to the mitogenic and neurotrophic properties of this neuropeptide in the central nervous system.

Original languageEnglish (US)
Pages (from-to)111-119
Number of pages9
JournalNeuropeptides
Volume37
Issue number2
DOIs
StatePublished - Apr 2003
Externally publishedYes

Fingerprint

Vasoactive Intestinal Peptide
Pituitary Adenylate Cyclase-Activating Polypeptide
Cytokines
Macrophage Colony-Stimulating Factor
Astrocytes
8-Bromo Cyclic Adenosine Monophosphate
Interleukin-3
Granulocyte Colony-Stimulating Factor
Vasoactive Intestinal Peptide Receptors
Capillary Electrophoresis
Neuropeptides
Complex Mixtures
Adenylyl Cyclases
Cytosol
Culture Media
Interleukin-6
Central Nervous System

Keywords

  • Granulocyte colony stimulating factor
  • Interleukin-3
  • Interleukin-6
  • Macrophage colony stimulating factor
  • Tumor necrosis factor-α

ASJC Scopus subject areas

  • Endocrinology
  • Neurology
  • Endocrine and Autonomic Systems
  • Cellular and Molecular Neuroscience

Cite this

Brenneman, D. E., Phillips, T. M., Hauser, J., Hill, J. M., Spong, C. Y., & Gozes, I. (2003). Complex array of cytokines released by vasoactive intestinal peptide. Neuropeptides, 37(2), 111-119. https://doi.org/10.1016/S0143-4179(03)00022-2

Complex array of cytokines released by vasoactive intestinal peptide. / Brenneman, Douglas E.; Phillips, Terry M.; Hauser, Janet; Hill, Joanna M.; Spong, Catherine Y.; Gozes, Illana.

In: Neuropeptides, Vol. 37, No. 2, 04.2003, p. 111-119.

Research output: Contribution to journalArticle

Brenneman, DE, Phillips, TM, Hauser, J, Hill, JM, Spong, CY & Gozes, I 2003, 'Complex array of cytokines released by vasoactive intestinal peptide', Neuropeptides, vol. 37, no. 2, pp. 111-119. https://doi.org/10.1016/S0143-4179(03)00022-2
Brenneman, Douglas E. ; Phillips, Terry M. ; Hauser, Janet ; Hill, Joanna M. ; Spong, Catherine Y. ; Gozes, Illana. / Complex array of cytokines released by vasoactive intestinal peptide. In: Neuropeptides. 2003 ; Vol. 37, No. 2. pp. 111-119.
@article{c8b90507872942a9a123d4b3ce0625f8,
title = "Complex array of cytokines released by vasoactive intestinal peptide",
abstract = "A complex mixture of five cytokines has been shown to be released by vasoactive intestinal peptide (VIP). Cytokines were measured in paired samples of culture medium and astroglial cytosol by capillary electrophoresis. This is the first description of VIP-mediated release for TNF-α, IL-3, G-CSF and M-CSF from astrocyte cultures. Kinetic studies after VIP treatment demonstrated a gradual but incomplete depletion of cytosolic cytokine levels, with differences observed among the cytokines. Significant increases in release were apparent within 15-30 min for all cytokines. As the recognized VIP receptors (VPAC1 and VPAC2) are linked to adenylate cyclase and also interact with pituitary adenylate cyclase activating polypeptide-38 (PACAP-38), both this homologous peptide and 8-bromo cAMP were investigated and compared to VIP-mediated release. Treatment with 1 mM 8-bromo cAMP produced cytokine release similar in amount to 0.1 nM PACAP-38, but significantly less (<50{\%}) in comparison to 0.1 nM VIP. PACAP-38 and VIP exhibited similar EC 50's for the release of G-CSF and TNF-α; however, the maximal release was 4-6 times greater for VIP than for PACAP-38. This similarity in potency suggested a VPAC-like receptor; however, the greater efficacy for VIP in comparison to PACAP-38, combined with a lack of cAMP production at subnanomolar concentrations of VIP, suggested a mechanism not currently associated with VPAC receptors. For M-CSF, IL-3 and IL-6, the EC50's of VIP were 3-30 times more potent than those of PACAP-38 in producing release. These studies suggested that multiple mechanisms mediate cytokine release in astrocytes: (1) a low efficacy release produced by PACAP-38 that is cAMP-mediated and (2) a high efficacy, VIP-preferring mechanism that was not linked to cAMP. In summary, subnanomolar concentrations of VIP released a complex array of cytokines from astrocytes that may contribute to the mitogenic and neurotrophic properties of this neuropeptide in the central nervous system.",
keywords = "Granulocyte colony stimulating factor, Interleukin-3, Interleukin-6, Macrophage colony stimulating factor, Tumor necrosis factor-α",
author = "Brenneman, {Douglas E.} and Phillips, {Terry M.} and Janet Hauser and Hill, {Joanna M.} and Spong, {Catherine Y.} and Illana Gozes",
year = "2003",
month = "4",
doi = "10.1016/S0143-4179(03)00022-2",
language = "English (US)",
volume = "37",
pages = "111--119",
journal = "Neuropeptides",
issn = "0143-4179",
publisher = "Churchill Livingstone",
number = "2",

}

TY - JOUR

T1 - Complex array of cytokines released by vasoactive intestinal peptide

AU - Brenneman, Douglas E.

AU - Phillips, Terry M.

AU - Hauser, Janet

AU - Hill, Joanna M.

AU - Spong, Catherine Y.

AU - Gozes, Illana

PY - 2003/4

Y1 - 2003/4

N2 - A complex mixture of five cytokines has been shown to be released by vasoactive intestinal peptide (VIP). Cytokines were measured in paired samples of culture medium and astroglial cytosol by capillary electrophoresis. This is the first description of VIP-mediated release for TNF-α, IL-3, G-CSF and M-CSF from astrocyte cultures. Kinetic studies after VIP treatment demonstrated a gradual but incomplete depletion of cytosolic cytokine levels, with differences observed among the cytokines. Significant increases in release were apparent within 15-30 min for all cytokines. As the recognized VIP receptors (VPAC1 and VPAC2) are linked to adenylate cyclase and also interact with pituitary adenylate cyclase activating polypeptide-38 (PACAP-38), both this homologous peptide and 8-bromo cAMP were investigated and compared to VIP-mediated release. Treatment with 1 mM 8-bromo cAMP produced cytokine release similar in amount to 0.1 nM PACAP-38, but significantly less (<50%) in comparison to 0.1 nM VIP. PACAP-38 and VIP exhibited similar EC 50's for the release of G-CSF and TNF-α; however, the maximal release was 4-6 times greater for VIP than for PACAP-38. This similarity in potency suggested a VPAC-like receptor; however, the greater efficacy for VIP in comparison to PACAP-38, combined with a lack of cAMP production at subnanomolar concentrations of VIP, suggested a mechanism not currently associated with VPAC receptors. For M-CSF, IL-3 and IL-6, the EC50's of VIP were 3-30 times more potent than those of PACAP-38 in producing release. These studies suggested that multiple mechanisms mediate cytokine release in astrocytes: (1) a low efficacy release produced by PACAP-38 that is cAMP-mediated and (2) a high efficacy, VIP-preferring mechanism that was not linked to cAMP. In summary, subnanomolar concentrations of VIP released a complex array of cytokines from astrocytes that may contribute to the mitogenic and neurotrophic properties of this neuropeptide in the central nervous system.

AB - A complex mixture of five cytokines has been shown to be released by vasoactive intestinal peptide (VIP). Cytokines were measured in paired samples of culture medium and astroglial cytosol by capillary electrophoresis. This is the first description of VIP-mediated release for TNF-α, IL-3, G-CSF and M-CSF from astrocyte cultures. Kinetic studies after VIP treatment demonstrated a gradual but incomplete depletion of cytosolic cytokine levels, with differences observed among the cytokines. Significant increases in release were apparent within 15-30 min for all cytokines. As the recognized VIP receptors (VPAC1 and VPAC2) are linked to adenylate cyclase and also interact with pituitary adenylate cyclase activating polypeptide-38 (PACAP-38), both this homologous peptide and 8-bromo cAMP were investigated and compared to VIP-mediated release. Treatment with 1 mM 8-bromo cAMP produced cytokine release similar in amount to 0.1 nM PACAP-38, but significantly less (<50%) in comparison to 0.1 nM VIP. PACAP-38 and VIP exhibited similar EC 50's for the release of G-CSF and TNF-α; however, the maximal release was 4-6 times greater for VIP than for PACAP-38. This similarity in potency suggested a VPAC-like receptor; however, the greater efficacy for VIP in comparison to PACAP-38, combined with a lack of cAMP production at subnanomolar concentrations of VIP, suggested a mechanism not currently associated with VPAC receptors. For M-CSF, IL-3 and IL-6, the EC50's of VIP were 3-30 times more potent than those of PACAP-38 in producing release. These studies suggested that multiple mechanisms mediate cytokine release in astrocytes: (1) a low efficacy release produced by PACAP-38 that is cAMP-mediated and (2) a high efficacy, VIP-preferring mechanism that was not linked to cAMP. In summary, subnanomolar concentrations of VIP released a complex array of cytokines from astrocytes that may contribute to the mitogenic and neurotrophic properties of this neuropeptide in the central nervous system.

KW - Granulocyte colony stimulating factor

KW - Interleukin-3

KW - Interleukin-6

KW - Macrophage colony stimulating factor

KW - Tumor necrosis factor-α

UR - http://www.scopus.com/inward/record.url?scp=0038113297&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038113297&partnerID=8YFLogxK

U2 - 10.1016/S0143-4179(03)00022-2

DO - 10.1016/S0143-4179(03)00022-2

M3 - Article

C2 - 12747943

AN - SCOPUS:0038113297

VL - 37

SP - 111

EP - 119

JO - Neuropeptides

JF - Neuropeptides

SN - 0143-4179

IS - 2

ER -